Cargando…

A systems pharmacology model for inflammatory bowel disease

MOTIVATION: The literature on complex diseases is abundant but not always quantitative. This is particularly so for Inflammatory Bowel Disease (IBD), where many molecular pathways are qualitatively well described but this information cannot be used in traditional quantitative mathematical models emp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balbas-Martinez, Violeta, Ruiz-Cerdá, Leire, Irurzun-Arana, Itziar, González-García, Ignacio, Vermeulen, An, Gómez-Mantilla, José David, Trocóniz, Iñaki F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841748/ https://www.ncbi.nlm.nih.gov/pubmed/29513758 http://dx.doi.org/10.1371/journal.pone.0192949

Ejemplares similares

Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer
por: Irurzun-Arana, Itziar, et al.
Publicado: (2018)

Beyond Deterministic Models in Drug Discovery and Development
por: Irurzun-Arana, Itziar, et al.
Publicado: (2020)

Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy
por: Irurzun-Arana, Itziar, et al.
Publicado: (2020)

Model‐Based Reverse Translation Between Veterinary and Human Medicine: The One Health Initiative
por: Schneider, Benjamin, et al.
Publicado: (2017)

Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015)

A quantitative systems pharmacology model for acute viral hepatitis B
por: Asín-Prieto, Eduardo, et al.
Publicado: (2021)

Semimechanistic models to relate noxious stimulation, movement, and pupillary dilation responses in the presence of opioids
por: Marco‐Ariño, Nicolás, et al.
Publicado: (2021)

Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
por: Saez, Angela, et al.
Publicado: (2023)

Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions
por: Varshneya, Meera, et al.
Publicado: (2020)

Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions
por: Varshneya, Meera, et al.
Publicado: (2021)

Investigational Treatments for COVID-19 May Increase Ventricular Arrhythmia Risk through Drug Interactions
por: Varshneya, Meera, et al.
Publicado: (2021)

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
por: Arana-Arri, Eunate, et al.
Publicado: (2017)

Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update
por: Valdés-González, Jose Antonio, et al.
Publicado: (2023)

Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease
por: Ke, Ping, et al.
Publicado: (2017)

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease
por: Lefevre, Pavine L C, et al.
Publicado: (2020)

Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease
por: Sebastian-delaCruz, Maialen, et al.
Publicado: (2020)

CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
por: Gomez-Bris, Raquel, et al.
Publicado: (2023)

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2018)

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease
por: Zheng, Yang, et al.
Publicado: (2021)

Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases
por: Levine, Anne E., et al.
Publicado: (2023)

Estimation of preterm labor immediacy by nonlinear methods
por: Malaina, Iker, et al.
Publicado: (2017)

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
por: Papa, Alfredo, et al.
Publicado: (2020)

Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease
por: Alves de Almeida, Ana Cristina, et al.
Publicado: (2017)

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
por: Lo, Wing-Cheong, et al.
Publicado: (2016)

Inflammatory Bowel Sugar Disease: A Pause From New Pharmacological Agents and an Embrace of Natural Therapy
por: Mahmoud, Anas, et al.
Publicado: (2023)

A network pharmacology approach to establish the pharmacological mechanism of JiaWeiXianJiTang on inflammatory bowel disease
por: Tao, Ling-Jia, et al.
Publicado: (2017)

A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 – Model Framework
por: Rogers, Katharine V., et al.
Publicado: (2020)

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
por: Pagnini, Cristiano, et al.
Publicado: (2019)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties
por: Liu, Yao, et al.
Publicado: (2022)

Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
por: Imbrizi, Marcello, et al.
Publicado: (2023)

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
por: Saez, Angela, et al.
Publicado: (2021)

Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial
por: Segarra, Sergi, et al.
Publicado: (2016)

Ocular Manifestations of Inflammatory Bowel Disease
por: Licona Vera, Erik, et al.
Publicado: (2023)

Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease
por: Wang, Dandan, et al.
Publicado: (2023)

Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain
por: Miranda-Bautista, José, et al.
Publicado: (2019)

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
por: Catalan-Serra, Ignacio, et al.
Publicado: (2018)

Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development
por: van Niel, Johannes, et al.
Publicado: (2022)

One evolutionarily selected amino acid variation is sufficient to provide functional specificity in the cold shock protein paralogs of Staphylococcus aureus
por: Catalan‐Moreno, Arancha, et al.
Publicado: (2020)

Herbal pair Huangqin-Baishao: mechanisms underlying inflammatory bowel disease by combined system pharmacology and cell experiment approach
por: Huang, Xiaoqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aailfjd2purome1ep80kdhig78